Sort
15,273 grants matching “antimicrobial resistance”
ArmR: a novel drug target and mediator of antibiotic resistance
$215,725David S Weiss · Emory University · R21 · FY2012 · AI
TASK A31: MIC Testing of GC Panel- FY17
$215,690Nathan Fisher · Southern Research Institute · N01 · FY2017 · AI
Probiotic Lactobacilli and Vaginal Epithelium
$215,616Ann E Stapleton · University Of Washington · R01 · FY2007 · DK
Molecular Archaeology: Vintage Beta Lactams for Resistant Gram Negative Infectio
$215,615Scott J. Hecker · Rempex Pharmaceuticals, Inc. · R21 · FY2012 · AI
Inhibitors of Nitro Drug Targets as Antimicrobials against Trichomonas Vaginalis
$215,600Patricia Jean Johnson · University Of California Los Angeles · R21 · FY2015 · AI
Enhancement of antimicrobics by electrical current
$215,562Robin Patel · Mayo Clinic Rochester · R21 · FY2007 · AI
Structure,Function, and Inhibition of Beta-lactamases
$215,465University Of California San Francisco · R01 · FY2004 · GM
New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis
$215,352Maha Farhat · Harvard Medical School · K01 · FY2019 · ES
Molecular and Structural Bases of Polymyxin Resistance
$215,319Eduardo A. Groisman · Washington University · R01 · FY2006 · AI
P. aeruginosa biofilm specific proteins and regulators
$215,297Karin Sauer · State University Of Ny,Binghamton · R15 · FY2007 · HL
Development of Artificial Agonists for a Bacterial Riboswitch
$215,250Juliane K Strauss-Soukup · Creighton University · R15 · FY2007 · GM
"Optical Tympanostomy Tube" for prevention and treatment of tympanostomy tube otorrhea
$215,250Tianhong Dai · Massachusetts General Hospital · R21 · FY2023 · DC
REGULATION OF P AERUGINOSA MOTILITY AND VIRULENCE
$215,221Wake Forest University Health Sciences · R01 · FY2001 · AI
Novel Antimicrobials for Eye Infections
$215,173Valentin V Rybenkov · University Of Oklahoma · R21 · FY2019 · EY
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics
$215,059David Elihu Greenberg · Ut Southwestern Medical Center · R21 · FY2014 · AI
Structure, Function and Inhibition of Beta-lactamases
$214,925Brian K. Shoichet · University Of California, San Francisco · R01 · FY2006 · GM
Blue light for drug resistant skin and soft tissue infections
$214,897Tianhong Dai · Massachusetts General Hospital · R21 · FY2015 · AI
Mucosal immunization for cross-protection against pneumonic burkholderia
$214,888Steven W. Dow · Colorado State University · U54 · FY2009 · AI
Collaborative Research: Polymeric Drug Delivery Systems and Biofilms in the Lung
$214,877Gerald W Young · University Of Akron · R01 · FY2010 · GM
Microbial altruists: Helping cohorts survive lethal drugs
$214,860University Of Louisville · R15 · FY2005 · AI
Amino acid prototrophy as a positive selective marker in Francisella
$214,839James Edward Bina · University Of Tennessee Health Sci Ctr · R21 · FY2008 · AI
Mechanistic Characterization of CRISPR-Cas Complexes that Mediate Pathogenicity in the Bacterium Francisella tularensis novicida (Rajan)
$214,822Rakhi Rajan · University Of Oklahoma · P20 · FY2017 · GM
Training in Interdisciplinary Research to Reduce Antimicrobial Resistance (TIRAR)
$214,806Elaine Lucille Larson · Columbia University Health Sciences · T90 · FY2011 · NR
Task E08: Lead Optimization Screening Assays for ADMET and Safety Profiling
$214,774Jacob Bode · Eurofins Panlabs, Inc. · N01 · FY2021 · AI
Antimicrobial Chronic Wound Bandage Treatment
$214,769Advanced Photodynamic Technologies, Inc. · R44 · FY2004 · NR